64Cu-SAR-bisPSMA PET for High-risk Prostate Cancer
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Age
- 18 and older
- Sex
- Male
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Diagnostic
- Participants needed
- 383 (estimated)
- Sponsor
- Clarity Pharmaceuticals Ltd · Industry
This trial is looking for men with untreated, high-risk prostate cancer. Participants will undergo a special scan called a PET scan to help find cancer spread before surgery.
You may be able to join if
- I am at least 18 years old.
- I have signed an informed consent form.
- I have untreated prostate cancer that has been confirmed by a test.
- I meet high-risk criteria for prostate cancer.
- I plan to have surgery for my prostate cancer.
You may not be able to join if
- I have received a high-energy radioisotope in the last several weeks.
- I am allergic to 64Cu-SAR-bisPSMA or any of its parts.
- I have a type of prostate cancer that is mostly small cell or neuroendocrine.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe aim for this study is to assess the diagnostic performance of 64Cu-SAR-bisPSMA PET to detect regional nodal metastases.
Loading trial locations…